Haldyn Glass Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 7:34 am

Quick Insight

Haldyn Glass Ltd, with a market capitalization of 699 Cr. and a P/E ratio of 37.1, appears to be trading at a premium in the Glass & Glass Products industry. The company's Return on Equity (ROE) of 9.08% and Return on Capital Employed (ROCE) of 12.7% indicate decent profitability, supported by an Operating Profit Margin (OPM) of 16.35%. However, the relatively high P/BV ratio of 2.20x suggests that the stock may be overvalued based on its book value. With a comfortable Interest Coverage Ratio (ICR) of 4.11x and a manageable Current Ratio of 107 days, Haldyn Glass seems financially stable despite its borrowing of ₹59Cr. Investors should monitor future earnings growth to justify the current valuation.

Competitors of Haldyn Glass Ltd

All Competitor Stocks of Haldyn Glass Ltd

Quarterly Result

Last Updated: August 19, 2025, 2:10 pm

Below is a detailed analysis of the quarterly data for Haldyn Glass Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 115.02 Cr.. The value appears strong and on an upward trend. It has increased from 83.61 Cr. (Mar 2025) to 115.02 Cr., marking an increase of 31.41 Cr..
• For Expenses, as of Jun 2025, the value is 98.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 69.94 Cr. (Mar 2025) to 98.30 Cr., marking an increase of 28.36 Cr..
• For Operating Profit, as of Jun 2025, the value is 16.72 Cr.. The value appears strong and on an upward trend. It has increased from 13.67 Cr. (Mar 2025) to 16.72 Cr., marking an increase of 3.05 Cr..
• For OPM %, as of Jun 2025, the value is 14.54%. The value appears to be declining and may need further review. It has decreased from 16.35% (Mar 2025) to 14.54%, marking a decrease of 1.81%.
• For Other Income, as of Jun 2025, the value is 1.40 Cr.. The value appears to be declining and may need further review. It has decreased from 3.14 Cr. (Mar 2025) to 1.40 Cr., marking a decrease of 1.74 Cr..
• For Interest, as of Jun 2025, the value is 3.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.90 Cr. (Mar 2025) to 3.62 Cr., marking a decrease of 0.28 Cr..
• For Depreciation, as of Jun 2025, the value is 7.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.34 Cr. (Mar 2025) to 7.60 Cr., marking an increase of 0.26 Cr..
• For Profit before tax, as of Jun 2025, the value is 6.90 Cr.. The value appears strong and on an upward trend. It has increased from 5.57 Cr. (Mar 2025) to 6.90 Cr., marking an increase of 1.33 Cr..
• For Tax %, as of Jun 2025, the value is 21.88%. The value appears to be increasing, which may not be favorable. It has increased from 19.21% (Mar 2025) to 21.88%, marking an increase of 2.67%.
• For Net Profit, as of Jun 2025, the value is 5.40 Cr.. The value appears strong and on an upward trend. It has increased from 4.50 Cr. (Mar 2025) to 5.40 Cr., marking an increase of 0.90 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.00. The value appears strong and on an upward trend. It has increased from 0.84 (Mar 2025) to 1.00, marking an increase of 0.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 19, 2025, 11:57 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:08 pm

Below is a detailed analysis of the balance sheet data for Haldyn Glass Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Reserves, as of Mar 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 194.00 Cr. (Mar 2024) to 210.00 Cr., marking an increase of 16.00 Cr..
• For Borrowings, as of Mar 2025, the value is 59.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 123.00 Cr. (Mar 2024) to 59.00 Cr., marking a decrease of 64.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 215.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 127.00 Cr. (Mar 2024) to 215.00 Cr., marking an increase of 88.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 490.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 450.00 Cr. (Mar 2024) to 490.00 Cr., marking an increase of 40.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 257.00 Cr.. The value appears strong and on an upward trend. It has increased from 240.00 Cr. (Mar 2024) to 257.00 Cr., marking an increase of 17.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 8.00 Cr..
• For Investments, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 6.00 Cr..
• For Other Assets, as of Mar 2025, the value is 183.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2024) to 183.00 Cr., marking an increase of 25.00 Cr..
• For Total Assets, as of Mar 2025, the value is 490.00 Cr.. The value appears strong and on an upward trend. It has increased from 450.00 Cr. (Mar 2024) to 490.00 Cr., marking an increase of 40.00 Cr..

Notably, the Reserves (210.00 Cr.) exceed the Borrowings (59.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Haldyn Glass Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 4.57 (Mar 24) to 3.50, marking a decrease of 1.07.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.49. This value is below the healthy minimum of 5. It has decreased from 4.56 (Mar 24) to 3.49, marking a decrease of 1.07.
• For Cash EPS (Rs.), as of Mar 25, the value is 7.88. This value is within the healthy range. It has increased from 7.06 (Mar 24) to 7.88, marking an increase of 0.82.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 40.07. It has increased from 37.13 (Mar 24) to 40.07, marking an increase of 2.94.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 40.07. It has increased from 37.13 (Mar 24) to 40.07, marking an increase of 2.94.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 70.99. It has increased from 55.58 (Mar 24) to 70.99, marking an increase of 15.41.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 11.42. This value is within the healthy range. It has increased from 10.30 (Mar 24) to 11.42, marking an increase of 1.12.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.07. This value is within the healthy range. It has decreased from 6.81 (Mar 24) to 6.07, marking a decrease of 0.74.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.29. This value is within the healthy range. It has decreased from 5.03 (Mar 24) to 3.29, marking a decrease of 1.74.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.53. This value is within the healthy range. It has decreased from 3.56 (Mar 24) to 2.53, marking a decrease of 1.03.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.50. This value is within the healthy range. It has decreased from 4.57 (Mar 24) to 3.50, marking a decrease of 1.07.
• For PBDIT Margin (%), as of Mar 25, the value is 16.09. This value is within the healthy range. It has decreased from 18.53 (Mar 24) to 16.09, marking a decrease of 2.44.
• For PBIT Margin (%), as of Mar 25, the value is 8.55. This value is below the healthy minimum of 10. It has decreased from 12.24 (Mar 24) to 8.55, marking a decrease of 3.69.
• For PBT Margin (%), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 10. It has decreased from 9.05 (Mar 24) to 4.63, marking a decrease of 4.42.
• For Net Profit Margin (%), as of Mar 25, the value is 3.55. This value is below the healthy minimum of 5. It has decreased from 6.41 (Mar 24) to 3.55, marking a decrease of 2.86.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.93. This value is below the healthy minimum of 8. It has decreased from 8.22 (Mar 24) to 4.93, marking a decrease of 3.29.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.73. This value is below the healthy minimum of 15. It has decreased from 12.30 (Mar 24) to 8.73, marking a decrease of 3.57.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.84. This value is below the healthy minimum of 10. It has decreased from 11.90 (Mar 24) to 9.84, marking a decrease of 2.06.
• For Return On Assets (%), as of Mar 25, the value is 3.84. This value is below the healthy minimum of 5. It has decreased from 5.46 (Mar 24) to 3.84, marking a decrease of 1.62.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.32, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.60 (Mar 24) to 0.58, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has decreased from 0.82 (Mar 24) to 0.81, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.09. This value is below the healthy minimum of 1.5. It has increased from 0.96 (Mar 24) to 1.09, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.66 (Mar 24) to 0.62, marking a decrease of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 4. It has decreased from 2.53 (Mar 24) to 1.89, marking a decrease of 0.64.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.31 (Mar 24) to 0.00, marking a decrease of 15.31.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.67 (Mar 24) to 0.00, marking a decrease of 8.67.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.69 (Mar 24) to 0.00, marking a decrease of 84.69.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.33 (Mar 24) to 0.00, marking a decrease of 91.33.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.11. This value is within the healthy range. It has decreased from 5.81 (Mar 24) to 4.11, marking a decrease of 1.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 3. It has decreased from 3.01 (Mar 24) to 1.91, marking a decrease of 1.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 588.82. It has decreased from 902.52 (Mar 24) to 588.82, marking a decrease of 313.70.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.54. This value is within the healthy range. It has decreased from 3.02 (Mar 24) to 1.54, marking a decrease of 1.48.
• For EV / EBITDA (X), as of Mar 25, the value is 9.59. This value is within the healthy range. It has decreased from 16.30 (Mar 24) to 9.59, marking a decrease of 6.71.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has decreased from 2.66 (Mar 24) to 1.24, marking a decrease of 1.42.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 84.68 (Mar 24) to 0.00, marking a decrease of 84.68.
• For Price / BV (X), as of Mar 25, the value is 2.20. This value is within the healthy range. It has decreased from 3.98 (Mar 24) to 2.20, marking a decrease of 1.78.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has decreased from 2.66 (Mar 24) to 1.24, marking a decrease of 1.42.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness